| Project/Area Number |
14570965
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Hematology
|
|---|
| Research Institution | Tokyo Medical Mand Dental University |
|---|
Principal Investigator |
YAMAOKA Shoji Tokyo Medical and Dental University, Department of Molecular Virology, Associate Professor, 大学院・医歯学総合研究科, 助教授 (90263160)
|
|---|
| Project Period (FY) |
2002 – 2003
|
| Project Status |
Completed (Fiscal Year 2003)
|
| Budget Amount *help |
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
|
|---|
| Keywords | ATL / leukemogenesis / NF-κB / IKK / NFKB2 / NF-kappa B / HTLV-1 / IKK1 / NEMO |
|---|
| Research Abstract |
Adult T-cell leukemia (ATL) is a fatal T cell malignancy that arises long after infection with human T-cell leukemia virus type I (HTLV-l). We reported previously that NF-κB was constitutively activated in ATL cells, although expression of the viral proteins was barely detectable including Tax which was known to persistently activate NF-κB. Here we demonstrate that ATL cells that do not express detectable Tax protein exhibit constitutive 1KB kinase (IKK) activity. Transfection studies revealed that a dominant negative form of IKK1, and not of IKK2 or NF-κB essential modulator (NEMO) suppressed constitutive NF-κB activity in ATL cells. This IKK activity was accompanied by elevated expression of p52, suggesting that the recently described non-canonical pathway of N F-KB activation operates in ATL cells. We finally show that specific inhibition of NE-KB by a super-repressor form of IKBcL in HTLV-l-infected T cells results in cell death regardless of Tax expression, providing definitive evidence of an essential role for NF-KB in the survival of ATL cells. In conclusion, the IKK complex is constitutively activated in ATL cells through a cellular mechanism distinct from that of Tax-mediated IKK activation. Further elucidation of this cellular mechanism should contribute to establishing a rationale for treatment of ATL.
|
